Skip to Main Content

Author Details

Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1997
39
21
PMIDPaper TitleJournal TitlePublished Year
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
34034815Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.Genome Med2021
34034815Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.Genome Med2021
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
32253233Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response.Clin Cancer Res2020
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
32253233Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response.Clin Cancer Res2020
30909073Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression.Neoplasia2019
30909073Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression.Neoplasia2019
29946024Sex-chromosome dosage effects on gene expression in humans.Proc Natl Acad Sci U S A2018
29946024Sex-chromosome dosage effects on gene expression in humans.Proc Natl Acad Sci U S A2018
28900283A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Sci Rep2017
28900283A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Sci Rep2017
28378747HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes.Sci Rep2017
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
28378747HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes.Sci Rep2017
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
24201445Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res2014
24201445Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res2014
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
25195635A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line.Int Arch Allergy Immunol2014
25195635A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line.Int Arch Allergy Immunol2014
24983628Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.PLoS One2014
22733138MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells.Oncogene2013
22733138MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells.Oncogene2013
23585473Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.J Clin Invest2013
23619298Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells.Carcinogenesis2013
23737987CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites.PLoS One2013
23619298Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells.Carcinogenesis2013
23737987CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites.PLoS One2013
23585473Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.J Clin Invest2013
22161874Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances.Genes Chromosomes Cancer2012
22161874Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances.Genes Chromosomes Cancer2012
21435437Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Am J Pathol2011
21435437Genome and transcriptome profiles of CD133-positive colorectal cancer cells.Am J Pathol2011
22040021Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes.Mol Cancer2011
22040021Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes.Mol Cancer2011
19927377Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines.Genes Chromosomes Cancer2010
19927377Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines.Genes Chromosomes Cancer2010
19602460Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.Cancer Genet Cytogenet2009
19691111Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.Genes Chromosomes Cancer2009
19602460Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.Cancer Genet Cytogenet2009
19691111Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.Genes Chromosomes Cancer2009
17210682Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.Cancer Res2007
17909011Cisplatin depletes TREX2 and causes Robertsonian translocations as seen in TREX2 knockout cells.Cancer Res2007
17599403ATM prevents the persistence and propagation of chromosome breaks in lymphocytes.Cell2007
17210682Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.Cancer Res2007
  • 1 - 50 of 78

Recommended Authors

University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
Institute of Cancer Sciences, University of Glasgow
Career Start Year 2006
Number of shared co-authors 0
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 9
Association for Molecular Pathology
Career Start Year 1999
Number of shared co-authors 0
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 0
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 1
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 0
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 0
University of Zurich
Career Start Year 1995
Number of shared co-authors 1
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 0
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 0
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 1
University of British Columbia
Career Start Year 1988
Number of shared co-authors 2
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 2
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 4
The University of Texas M. D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 1
Broad Institute
Career Start Year 1983
Number of shared co-authors 4
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 3
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 38
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Universitat Autonoma de Barcelona
Co-authored papers 6
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Vertex Pharmaceuticals
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Heart Lung and Blood Institute Division of Intramural Research
Co-authored papers 2
University Medical Center Schleswig-Holstein
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
National Center for Advancing Translational Sciences
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 1
Chalmers University of Technology
Co-authored papers 1
and Blood Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1